Trial Profile
Phase I/II clinical trial on thymosin alfa 1 [thymalfasin] of allogeneic hematopoietic transplantation
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary)
- Indications Cytomegalic inclusion disorders; Graft-versus-host disease; Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 15 Jan 2008 New trial record.